Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

October 25, 2017
Otsuka Pharmaceutical

Heat Disorders Prevention - Communication Project "Hitosuzumi Awards 2017" Otsuka Pharmaceutical Recognized with "Team Excellence" and "Top Runner" Awards
October 20, 2017
Taiho Pharmaceutical

Health Canada Grants Priority Review Status to TAS-102 (brand name in Japan: "LONSURFⓇ") for Refractory Metastatic Colorectal Cancer
October 17, 2017
Otsuka Pharmaceutical

Otsuka Submits a Japan NDA for Nalmefene, a Drug to Reduce Alcohol Consumption in Alcohol-Dependent Patients
October 12, 2017
Otsuka Pharmaceutical

Otsuka and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole in Patients with Bipolar I Disorder
October 12, 2017
Otsuka Holdings Otsuka Pharmaceutical

Otsuka and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole in Patients with Bipolar I Disorder
October 10, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Comprehensive Partnership with Kochi Prefecture
October 5, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical Releases Pitas Sore Throat Troche in Japan on October 5 A Sticker-type Troche to be Placed on the Roof of the Mouth That is Helpful in Business Meetings
October 4, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical to Participate in Japan Healthcare Venture Summit 2017
September 21, 2017
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory completes acquisition of additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited
September 21, 2017
Otsuka Holdings Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory completes acquisition of additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited
September 20, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical Concludes Option and License Agreement with Arcus Biosciences
September 13, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters Into Health Promotion Partnership with Ehime Prefecture
September 7, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical Releases Harncare Granules Nationwide in Japan on Thursday, September 7ーan Effective Herbal Remedy to Improve Urinary Function by Warming up the Body from the Inside.
September 1, 2017
Otsuka Holdings Otsuka Pharmaceutical

Otsuka Pharmaceutical Completes Acquisition of Daiya
August 25, 2017
Taiho Pharmaceutical

Antitumor Agent Abraxane® I.V. Infusion 100 mg Approved for Additional Dosage and Administration for Gastric Cancer
August 24, 2017
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory obtains import drug license of Cefazolin Sodium for Injection/Sodium Chloride Injection in China
August 24, 2017
Otsuka Pharmaceutical

Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries
August 23, 2017
Otsuka Pharmaceutical Factory

Otsuka OPV, the Vietnamese subsidiary of Otsuka Pharmaceutical Factory announces the construction of a new factory for the distribution of high quality IV solution products
August 21, 2017
Otsuka Pharmaceutical

Extremely Fine-textured Foam Facial Cleanser Introducing UL·OS Face Wash for Skin Care Evolution of Face Wash from "Cleansing" to "Skin Care"
August 15, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Participates in Summer Events in Tokushima Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink Presents Awa Odori Sound Festival
July 31, 2017
Otsuka Holdings Otsuka Pharmaceutical

ABILIFY MAINTENA® (aripiprazole) for Extended-Release Injectable Suspension Approved by U.S. FDA for Maintenance Monotherapy Treatment of Bipolar I Disorder
July 29, 2017
Otsuka Pharmaceutical

ABILIFY MAINTENA® (aripiprazole) for Extended-Release Injectable Suspension Approved by U.S. FDA for Maintenance Monotherapy Treatment of Bipolar I Disorder
July 28, 2017
Otsuka Pharmaceutical

Otsuka Submits New Drug Application in Japan for Aripiprazole Sertraline Combination Tablets
July 27, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Acquire Daiya, a Rapidly Growing Plant-Based Food Company in North America
July 27, 2017
Otsuka Holdings Otsuka Pharmaceutical

Otsuka Pharmaceutical to Acquire Daiya, a Rapidly Growing Plant-Based Food Company in North America
July 25, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Serves as Special Sponsor of Summer Inter-High School Athletic Meeting for Fourth Consecutive Year Event Venue Enlivened with Heat Stroke Prevention Posters and Banners Submitted by Local High School Students
July 24, 2017
Otsuka Pharmaceutical

"Quick Navi-Flu2" Influenza Diagnostic Kit to Launch in Japan
July 20, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Partnership Agreement with Wakayama Prefecture
July 18, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Establishes New Functional Food and Beverage Affiliate in Thailand
July 18, 2017
Otsuka Pharmaceutical

Otsuka and R-Pharm Announce Licensing Agreement to Commercialize Deltyba™ (Delamanid) for Multidrug-Resistant Tuberculosis (MDR-TB) in Russia and CIS Countries